Literature DB >> 23320131

P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control.

Tobias Engel1, Alba Jimenez-Pacheco, Maria Teresa Miras-Portugal, Miguel Diaz-Hernandez, David C Henshall.   

Abstract

The P2X7 receptor is an ATP-gated non-selective cation-permeable ionotropic receptor selectively expressed in neurons and glia in the brain. Activation of the P2X7 receptor has been found to modulate neuronal excitability in the hippocampus and it has also been linked to microglia activation and neuroinflammatory responses. Accordingly, interest developed on the P2X7 receptor in disorders of the nervous system, including epilepsy. Studies show that expression of the P2X7 receptor is elevated in damaged regions of the brain after prolonged seizures (status epilepticus) in both neurons and glia. P2X7 receptor expression is also increased in the hippocampus in experimental epilepsy. Recent data show that mice lacking the P2X7 receptor display altered susceptibility to status epilepticus and that drugs targeting the P2X7 receptor have potent anticonvulsant effects. Together, this suggests that P2X7 receptor ligands may be useful adjunctive treatments for refractory status epilepticus or perhaps pharmacoresistant epilepsy. This review summarizes the evidence of P2X7 receptor involvement in the pathophysiology of epilepsy and the potential of drugs targeting this receptor for seizure control.

Entities:  

Keywords:  Adenosine 5’-triphosphate; anticonvulsant; epilepsy; hippocampal sclerosis; interleukin 1 beta; status epilepticus

Year:  2012        PMID: 23320131      PMCID: PMC3544219     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  101 in total

1.  Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems.

Authors:  S A Deuchars; L Atkinson; R E Brooke; H Musa; C J Milligan; T F Batten; N J Buckley; S H Parson; J Deuchars
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 2.  P2 receptors and neuronal injury.

Authors:  Heike Franke; Ute Krügel; Peter Illes
Journal:  Pflugers Arch       Date:  2006-04-28       Impact factor: 3.657

3.  Modulation by adenine nucleotides of epileptiform activity in the CA3 region of rat hippocampal slices.

Authors:  F M Ross; M J Brodie; T W Stone
Journal:  Br J Pharmacol       Date:  1998-01       Impact factor: 8.739

4.  Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages.

Authors:  Suran L Fernando; Bernadette M Saunders; Ronald Sluyter; Kristen K Skarratt; James S Wiley; Warwick J Britton
Journal:  J Infect Dis       Date:  2005-05-31       Impact factor: 5.226

5.  Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling.

Authors:  Elena Avignone; Lauriane Ulmann; Françoise Levavasseur; François Rassendren; Etienne Audinat
Journal:  J Neurosci       Date:  2008-09-10       Impact factor: 6.167

Review 6.  The neurobiology of epilepsy.

Authors:  Helen E Scharfman
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

7.  Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat.

Authors:  N Braun; Y Zhu; J Krieglstein; C Culmsee; H Zimmermann
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

8.  A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice.

Authors:  Annette Nicke; Yung-Hui Kuan; Marianela Masin; Jürgen Rettinger; Benjamin Marquez-Klaka; Olaf Bender; Dariusz C Górecki; Ruth D Murrell-Lagnado; Florentina Soto
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

9.  Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice.

Authors:  Donald E Kimbler; Jessica Shields; Nathan Yanasak; John R Vender; Krishnan M Dhandapani
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

10.  P2X7 receptor activation ameliorates CA3 neuronal damage via a tumor necrosis factor-α-mediated pathway in the rat hippocampus following status epilepticus.

Authors:  Ji-Eun Kim; Hea Jin Ryu; Tae-Cheon Kang
Journal:  J Neuroinflammation       Date:  2011-06-02       Impact factor: 8.322

View more
  21 in total

1.  Silencing of P2X7R by RNA interference in the hippocampus can attenuate morphological and behavioral impact of pilocarpine-induced epilepsy.

Authors:  Rebeca Padrão Amorim; Michelle Gasparetti Leão Araújo; Jorge Valero; Iscia Lopes-Cendes; Vinicius Davila Bitencourt Pascoal; João Oliveira Malva; Maria José da Silva Fernandes
Journal:  Purinergic Signal       Date:  2017-07-13       Impact factor: 3.765

Review 2.  Modulation of neuronal excitability by immune mediators in epilepsy.

Authors:  Valentina Iori; Federica Frigerio; Annamaria Vezzani
Journal:  Curr Opin Pharmacol       Date:  2015-11-26       Impact factor: 5.547

3.  Analyzing the Role of the P2X7 Receptor in Epilepsy.

Authors:  Mariana Alves; Laura de Diego-Garcia; Tobias Engel
Journal:  Methods Mol Biol       Date:  2022

4.  Variations of ATP and its metabolites in the hippocampus of rats subjected to pilocarpine-induced temporal lobe epilepsy.

Authors:  Flávia Doná; Isaltino Marcelo Conceição; Henning Ulrich; Eliane Beraldi Ribeiro; Thalma Ariani Freitas; Ana Leonor Abrahao Nencioni; Maria José da Silva Fernandes
Journal:  Purinergic Signal       Date:  2016-03-03       Impact factor: 3.765

5.  Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.

Authors:  Alba Jimenez-Pacheco; Miguel Diaz-Hernandez; Marina Arribas-Blázquez; Amaya Sanz-Rodriguez; Luis A Olivos-Oré; Antonio R Artalejo; Mariana Alves; Michael Letavic; M Teresa Miras-Portugal; Ronan M Conroy; Norman Delanty; Michael A Farrell; Donncha F O'Brien; Anindya Bhattacharya; Tobias Engel; David C Henshall
Journal:  J Neurosci       Date:  2016-06-01       Impact factor: 6.167

Review 6.  Neuroinflammatory targets and treatments for epilepsy validated in experimental models.

Authors:  Eleonora Aronica; Sebastian Bauer; Yuri Bozzi; Matteo Caleo; Raymond Dingledine; Jan A Gorter; David C Henshall; Daniela Kaufer; Sookyong Koh; Wolfgang Löscher; Jean-Pierre Louboutin; Michele Mishto; Braxton A Norwood; Eleonora Palma; Michael O Poulter; Gaetano Terrone; Annamaria Vezzani; Rafal M Kaminski
Journal:  Epilepsia       Date:  2017-07       Impact factor: 5.864

Review 7.  Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?

Authors:  Joeri Van Liefferinge; Ann Massie; Jeanelle Portelli; Giuseppe Di Giovanni; Ilse Smolders
Journal:  Front Cell Neurosci       Date:  2013-08-30       Impact factor: 5.505

Review 8.  Tissue-nonspecific Alkaline Phosphatase Regulates Purinergic Transmission in the Central Nervous System During Development and Disease.

Authors:  Álvaro Sebastián-Serrano; Laura de Diego-García; Carlos Martínez-Frailes; Jesús Ávila; Herbert Zimmermann; José Luis Millán; María Teresa Miras-Portugal; Miguel Díaz-Hernández
Journal:  Comput Struct Biotechnol J       Date:  2014-12-15       Impact factor: 7.271

Review 9.  P2X and P2Y receptors—role in the pathophysiology of the nervous system.

Authors:  Kamila Puchałowicz; Maciej Tarnowski; Irena Baranowska-Bosiacka; Dariusz Chlubek; Violetta Dziedziejko
Journal:  Int J Mol Sci       Date:  2014-12-18       Impact factor: 5.923

Review 10.  P2X receptors as targets for the treatment of status epilepticus.

Authors:  David C Henshall; Miguel Diaz-Hernandez; M Teresa Miras-Portugal; Tobias Engel
Journal:  Front Cell Neurosci       Date:  2013-11-26       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.